Skip to content
Search

Latest Stories

Boots reports 5.9% retail sales growth in Q2 2024

Boots reports 5.9% retail sales growth in Q2 2024

Digital sales via its website and app grew by 16.8 per cent, driven by strong demand for beauty and personal care products.

Boots registered a twelfth consecutive quarter of retail market share growth, with a reported retail sales increase of 5.9 per cent for the three months ending on 29 February 2024.


This impressive growth comes on top of a 16 per cent increase recorded during the same period in the previous year, the UK’s leading health and beauty retailer revealed.

Strong growth was observed across digital platforms, namely Boots.com and the Boots app, with a 16.8 per cent surge in digital sales, particularly driven by “strong sales of beauty and personal care products.”

The growth of in-store sales remained consistent, registering a 4.5 per cent increase, with flagship, shopping center, and travel stores demonstrating particularly strong performance.

Boots’ airport stores recorded double-digit year-on-year growth, supported by the inauguration of a new store at Luton and refurbishments at Gatwick and Manchester.

Its sales increased steadily in the lead-up to Christmas, with beauty and cosmetic gift sets, many of which were own-brand, performing well.

The opening of the beauty-only store in London’s Battersea Power Station in December along with the launch of even more new beauty brands cemented Boots' position as the UK’s leading beauty retailer.

“The store’s launch, along with upgrades to a number of Boots beauty halls across the UK, contributed to overall beauty sales growth with particularly strong gains in skincare,” the company said.

In the healthcare sector, Boots experienced nearly 40 per cent growth in services, primarily fueled by the consistent strong performance of Boots Online Doctor. Weight loss turned out to be the most popular and fastest-growing service, it said.

Boots reported steady sales growth in retail health, propelled by its own-label range, notably the vitamins and pain relief products.

Within the first few weeks of its operation, Boots pharmacists conducted over 20,000 Pharmacy First consultations, indicating a strong reception by customers.

Sebastian James, CEO of Boots UK & ROI, said he was “really pleased” to see the sustained positive momentum across the whole business.  He noted an increase in their customers both online and in-store, along with significant growth in the healthcare and beauty sectors, which are key markets for the company.

“I am particularly proud of our pharmacy team, who worked incredibly hard to launch Pharmacy First in England; the feedback from patients has been brilliant and it is clear that they value the convenience of accessing a trusted healthcare professional on their local high street with no appointment necessary,” James said.

“We see a significant opportunity to do more in this area, helping customers to get better quickly, supporting communities and relieving the burden on the NHS,” he added.

Launched in England in January, the service aims to alleviate pressure on GPs by expanding the role of pharmacists to advise and prescribe for the treatment of seven common health conditions including earache, sore throat and sinusitis.

Boots operates a network of more than 2,100 stores across the UK, ranging from local community pharmacies to large destination health and beauty stores, and employs over 52,000 team members nationwide.

The company is part of Walgreens Boots Alliance, which is a global leader in pharmacy-led, health and wellbeing retail.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less